Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia
Ronaldo C. Go, Joshua Josephs(Hackensack University Medical Center), Waqas ur Rahman(Birmingham City University), Sung Hung(Hackensack University Medical Center), Lesley Philip(Hackensack University Medical Center), Khurram Sarfraz(Hackensack University Medical Center), Justin J. Panthappattu(Hackensack University Medical Center), Anuja Pradhan(Hackensack University Medical Center), Michael Marafelias(Hackensack University Medical Center), Neel Shah(Hackensack University Medical Center), Hyun Woo Im(Hackensack University Medical Center), Yukiko Oe(Columbia University), Sean Sadikot(Hackensack University Medical Center), Sapan Shah(Hindu College of Pharmacy), Karan Omidvari(Hackensack University Medical Center), Keith Rose, Chandni Bheeman(Hackensack University Medical Center), Roshan Shah(Hackensack University Medical Center), Themba Nyirenda(Hackensack University Medical Center), Steven J. Sperber(Hackensack University Medical Center), Sophia Dar(Hackensack University Medical Center)
Cited by 12
Related Papers
Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
|PLoS ONE|2020|334
Parkinson Disease Affects Peripheral Sensory Nerves in the Pharynx
|Journal of Neuropathology & Experimental Neurology|2013|155
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
|PLoS ONE|2020|144
Incidence of Renal Artery Pseudoaneurysm Following Open and Minimally Invasive Partial Nephrectomy: A Systematic Review and Comparative Analysis
|The Journal of Urology|2012|121
Health care workers and disaster preparedness: barriers to and facilitators of willingness to respond
|International Journal of Emergency Medicine|2012|89